Our Scientists
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance.
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their impact on driving and cognitive performance.
My academic training and research experience have provided me with an excellent background in multiple psychological disciplines including neurobiology, neuropsychology, and neuropsychopharmacology.
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Most of my previous research has focused on psychological trauma, trauma-related disorders, trauma-focused psychotherapies, as well as autobiographical memory.
My name is Dr. Peter van Ruitenbeek and I work as an assistant professor. That means I teach and do research at the faculty of psychology and neuroscience.
I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.
I am a PhD candidate in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
We are also evaluating subjective effects, safety, tolerability, and possible changes in personality, social cognition and well-being.
My name is Hongyu, and I am a researcher from China. After completing my undergraduate degree in anesthesiology and obtaining a master's degree in psychiatry from a prestigious medical university in China.
I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment of chronic pain.
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.
My research focuses on the effects of stress, sleep deprivation, on cognitive biases, by using the transdiagnostic rDOC approach, and see whether psychedelics such as LSD, Psilocybin and even non-hallucinogenic psychedelics can reverse these effects.
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles (Exosomes).